ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a company update. Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results